Table 3.
Eradication rate from therapy for the failures at other clinics during the periods without (June, 2004 to October, 2005) and with (November, 2005 to August, 2010) a routine genetic test for CYP2C19
| Subjects | 2004–2005 | 2005–2010 | |||
| Untested | *1*1 | Other genotypes | Untested | Total | |
| n (%) | n (%) | n (%) | n (%) | n (%) | |
| Visited | 11 (100) | - | - | - | 61 (100) |
| Infected | 11 (100.0) | 24 | 26 | 5 | 55 (90.2) |
| Treated | 7 | 19 | 26 | 5 | 50 |
| Succeeded | 5 (100.0*) | 12 (100.0*) | 12 (92.3*) | 2 (100.0*) | 26 (96.3*) |
| Failed | 0 | 0 | 1 (7.7*) | 0 | 1 (3.7*) |
| Not evaluated | 2 | 7 | 13 | 3 | 23 |
* Rate excluding those unevaluated